Selected research
Market Structure
Global Automatic Parallel Peptide Synthesiser Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Automatic Parallel Peptide Synthesiser market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Automatic Parallel Peptide Synthesiser is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Automatic Parallel Peptide Synthesiser is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Automatic Parallel Peptide Synthesiser is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Automatic Parallel Peptide Synthesiser is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Automatic Parallel Peptide Synthesiser include Biotage, MultiSynTech GmbH, Activotec, CEM GmbH and AAPPTEC, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
On the production side, the report examines Automatic Parallel Peptide Synthesiser output, growth rates, and market shares by manufacturer and by region (at regional and country level) for 2021-2026, with forecasts through 2032.
On the consumption side, the report analyzes sales of Automatic Parallel Peptide Synthesiser by region (regional and country level), company, type, and application for 2021-2026 and provides forecasts through 2032.
The report provides an overview of the global Automatic Parallel Peptide Synthesiser market in terms of capacity, output, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Automatic Parallel Peptide Synthesiser and consumption patterns in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Automatic Parallel Peptide Synthesiser sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by type and application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Automatic Parallel Peptide Synthesiser market size, projected growth trends, production technologies, key applications, and end-use industries.
Automatic Parallel Peptide Synthesiser Segment by Company
Biotage
MultiSynTech GmbH
Activotec
CEM GmbH
AAPPTEC
Automatic Parallel Peptide Synthesiser Segment by Type
Semi-automatic
Fully Automatic
Automatic Parallel Peptide Synthesiser Segment by Application
Laboratory
Medical
Other
Automatic Parallel Peptide Synthesiser Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Automatic Parallel Peptide Synthesiser market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Automatic Parallel Peptide Synthesiser and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Automatic Parallel Peptide Synthesiser.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Automatic Parallel Peptide Synthesiser market, including product definition, global market growth prospects, production value, capacity, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Automatic Parallel Peptide Synthesiser industry.
Chapter 3: Detailed analysis of Automatic Parallel Peptide Synthesiser market competition landscape. Including Automatic Parallel Peptide Synthesiser manufacturers' output value, output and average price from 2021 to 2026, as well as competition analysis indicators such as origin, product type, application, merger and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 7: Production/Production Value of Automatic Parallel Peptide Synthesiser by region. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 8: Consumption of Automatic Parallel Peptide Synthesiser in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Semi-automatic
- Fully Automatic
Applications
- Laboratory
- Medical
- Other
Companies covered
- Biotage
- MultiSynTech GmbH
- Activotec
- CEM GmbH
- AAPPTEC
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Automatic Parallel Peptide Synthesiser Production Value Estimates and Forecasts (2021-2032)
- 1.2.2 Global Automatic Parallel Peptide Synthesiser Production Capacity Estimates and Forecasts (2021-2032)
- 1.2.3 Global Automatic Parallel Peptide Synthesiser Production Estimates and Forecasts (2021-2032)
- 1.2.4 Global Automatic Parallel Peptide Synthesiser Market Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 Global Automatic Parallel Peptide Synthesiser Market Dynamics
- 2.1 Automatic Parallel Peptide Synthesiser Industry Trends
- 2.2 Automatic Parallel Peptide Synthesiser Industry Drivers
- 2.3 Automatic Parallel Peptide Synthesiser Industry Opportunities and Challenges
- 2.4 Automatic Parallel Peptide Synthesiser Industry Restraints
3 Automatic Parallel Peptide Synthesiser Market by Manufacturers
- 3.1 Global Automatic Parallel Peptide Synthesiser Production Value by Manufacturers (2021-2026)
- 3.2 Global Automatic Parallel Peptide Synthesiser Production by Manufacturers (2021-2026)
- 3.3 Global Automatic Parallel Peptide Synthesiser Average Price by Manufacturers (2021-2026)
- 3.4 Global Automatic Parallel Peptide Synthesiser Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Automatic Parallel Peptide Synthesiser Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Automatic Parallel Peptide Synthesiser Manufacturers, Product Type & Application
- 3.7 Global Automatic Parallel Peptide Synthesiser Manufacturers Established Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Automatic Parallel Peptide Synthesiser Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Automatic Parallel Peptide Synthesiser Players Market Share by Production Value in 2025
- 3.8.3 2025 Automatic Parallel Peptide Synthesiser Tier 1, Tier 2, and Tier 3
4 Automatic Parallel Peptide Synthesiser Market by Type
- 4.1 Automatic Parallel Peptide Synthesiser Type Introduction
- 4.1.1 Semi-automatic
- 4.1.2 Fully Automatic
- 4.2 Global Automatic Parallel Peptide Synthesiser Production by Type
- 4.2.1 Global Automatic Parallel Peptide Synthesiser Production by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Automatic Parallel Peptide Synthesiser Production by Type (2021-2032)
- 4.2.3 Global Automatic Parallel Peptide Synthesiser Production Market Share by Type (2021-2032)
- 4.3 Global Automatic Parallel Peptide Synthesiser Production Value by Type
- 4.3.1 Global Automatic Parallel Peptide Synthesiser Production Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Automatic Parallel Peptide Synthesiser Production Value by Type (2021-2032)
- 4.3.3 Global Automatic Parallel Peptide Synthesiser Production Value Market Share by Type (2021-2032)
5 Automatic Parallel Peptide Synthesiser Market by Application
- 5.1 Automatic Parallel Peptide Synthesiser Application Introduction
- 5.1.1 Laboratory
- 5.1.2 Medical
- 5.1.3 Other
- 5.2 Global Automatic Parallel Peptide Synthesiser Production by Application
- 5.2.1 Global Automatic Parallel Peptide Synthesiser Production by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Automatic Parallel Peptide Synthesiser Production by Application (2021-2032)
- 5.2.3 Global Automatic Parallel Peptide Synthesiser Production Market Share by Application (2021-2032)
- 5.3 Global Automatic Parallel Peptide Synthesiser Production Value by Application
- 5.3.1 Global Automatic Parallel Peptide Synthesiser Production Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Automatic Parallel Peptide Synthesiser Production Value by Application (2021-2032)
- 5.3.3 Global Automatic Parallel Peptide Synthesiser Production Value Market Share by Application (2021-2032)
6 Company Profiles
- 6.1 Biotage
- 6.1.1 Biotage Company Information
- 6.1.2 Biotage Business Overview
- 6.1.3 Biotage Automatic Parallel Peptide Synthesiser Production, Value and Gross Margin (2021-2026)
- 6.1.4 Biotage Automatic Parallel Peptide Synthesiser Product Portfolio
- 6.1.5 Biotage Recent Developments
- 6.2 MultiSynTech GmbH
- 6.2.1 MultiSynTech GmbH Company Information
- 6.2.2 MultiSynTech GmbH Business Overview
- 6.2.3 MultiSynTech GmbH Automatic Parallel Peptide Synthesiser Production, Value and Gross Margin (2021-2026)
- 6.2.4 MultiSynTech GmbH Automatic Parallel Peptide Synthesiser Product Portfolio
- 6.2.5 MultiSynTech GmbH Recent Developments
- 6.3 Activotec
- 6.3.1 Activotec Company Information
- 6.3.2 Activotec Business Overview
- 6.3.3 Activotec Automatic Parallel Peptide Synthesiser Production, Value and Gross Margin (2021-2026)
- 6.3.4 Activotec Automatic Parallel Peptide Synthesiser Product Portfolio
- 6.3.5 Activotec Recent Developments
- 6.4 CEM GmbH
- 6.4.1 CEM GmbH Company Information
- 6.4.2 CEM GmbH Business Overview
- 6.4.3 CEM GmbH Automatic Parallel Peptide Synthesiser Production, Value and Gross Margin (2021-2026)
- 6.4.4 CEM GmbH Automatic Parallel Peptide Synthesiser Product Portfolio
- 6.4.5 CEM GmbH Recent Developments
- 6.5 AAPPTEC
- 6.5.1 AAPPTEC Company Information
- 6.5.2 AAPPTEC Business Overview
- 6.5.3 AAPPTEC Automatic Parallel Peptide Synthesiser Production, Value and Gross Margin (2021-2026)
- 6.5.4 AAPPTEC Automatic Parallel Peptide Synthesiser Product Portfolio
- 6.5.5 AAPPTEC Recent Developments
7 Global Automatic Parallel Peptide Synthesiser Production by Region
- 7.1 Global Automatic Parallel Peptide Synthesiser Production by Region: 2021 VS 2025 VS 2032
- 7.2 Global Automatic Parallel Peptide Synthesiser Production by Region (2021-2032)
- 7.2.1 Global Automatic Parallel Peptide Synthesiser Production by Region (2021-2026)
- 7.2.2 Global Automatic Parallel Peptide Synthesiser Production Forecast by Region (2027-2032)
- 7.3 Global Automatic Parallel Peptide Synthesiser Production by Region: 2021 VS 2025 VS 2032
- 7.4 Global Automatic Parallel Peptide Synthesiser Production Value by Region (2021-2032)
- 7.4.1 Global Automatic Parallel Peptide Synthesiser Production Value by Region (2021-2026)
- 7.4.2 Global Automatic Parallel Peptide Synthesiser Production Value by Region (2027-2032)
- 7.5 Global Automatic Parallel Peptide Synthesiser Market Price Analysis by Region (2021-2032)
- 7.6 Regional Production Value Trends (2021-2032)
- 7.6.1 North America Automatic Parallel Peptide Synthesiser Production Value (2021-2032)
- 7.6.2 Europe Automatic Parallel Peptide Synthesiser Production Value (2021-2032)
- 7.6.3 Asia-Pacific Automatic Parallel Peptide Synthesiser Production Value (2021-2032)
- 7.6.4 South America Automatic Parallel Peptide Synthesiser Production Value (2021-2032)
- 7.6.5 Middle East & Africa Automatic Parallel Peptide Synthesiser Production Value (2021-2032)
8 Global Automatic Parallel Peptide Synthesiser Consumption by Region
- 8.1 Global Automatic Parallel Peptide Synthesiser Consumption by Region: 2021 VS 2025 VS 2032
- 8.2 Global Automatic Parallel Peptide Synthesiser Consumption by Region (2021-2032)
- 8.2.1 Global Automatic Parallel Peptide Synthesiser Consumption by Region (2021-2026)
- 8.2.2 Global Automatic Parallel Peptide Synthesiser Consumption by Region (2027-2032)
- 8.3 North America
- 8.3.1 North America Automatic Parallel Peptide Synthesiser Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3.2 North America Automatic Parallel Peptide Synthesiser Consumption by Country (2021-2032)
- 8.3.3 U.S.
- 8.3.4 Canada
- 8.3.5 Mexico
- 8.4 Europe
- 8.4.1 Europe Automatic Parallel Peptide Synthesiser Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.4.2 Europe Automatic Parallel Peptide Synthesiser Consumption by Country (2021-2032)
- 8.4.3 Germany
- 8.4.4 France
- 8.4.5 U.K.
- 8.4.6 Italy
- 8.4.7 Netherlands
- 8.5 Asia Pacific
- 8.5.1 Asia Pacific Automatic Parallel Peptide Synthesiser Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.5.2 Asia Pacific Automatic Parallel Peptide Synthesiser Consumption by Country (2021-2032)
- 8.5.3 China
- 8.5.4 Japan
- 8.5.5 South Korea
- 8.5.6 Southeast Asia
- 8.5.7 India
- 8.5.8 Australia
- 8.6 South America
- 8.6.1 South America Automatic Parallel Peptide Synthesiser Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.6.2 South America Automatic Parallel Peptide Synthesiser Consumption by Country (2021-2032)
- 8.6.3 Brazil
- 8.6.4 Argentina
- 8.6.5 Chile
- 8.6.6 Colombia
- 8.7 Middle East & Africa
- 8.7.1 Middle East & Africa Automatic Parallel Peptide Synthesiser Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.7.2 Middle East & Africa Automatic Parallel Peptide Synthesiser Consumption by Country (2021-2032)
- 8.7.3 Egypt
- 8.7.4 South Africa
- 8.7.5 Israel
- 8.7.6 Türkiye
- 8.7.7 GCC Countries
9 Value Chain and Sales Channels Analysis
- 9.1 Automatic Parallel Peptide Synthesiser Value Chain Analysis
- 9.1.1 Automatic Parallel Peptide Synthesiser Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Automatic Parallel Peptide Synthesiser Production Mode & Process
- 9.2 Automatic Parallel Peptide Synthesiser Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Automatic Parallel Peptide Synthesiser Distributors
- 9.2.3 Automatic Parallel Peptide Synthesiser Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst